Bharat Biotech inks pact with WU's School of Medicine for COVID-19 intranasal vaccine

Bharat Biotech on Wednesday signed a licensing agreement with Washington University School of Medicine in St Louis for a novel "chimp-adenovirus" (Chimpanzee adenovirus), single dose intranasal vaccine for COVID-19. According to a press release issued by the city-based vaccine maker, Bharat Biotech owns the rights to distribute the vaccine in all markets except the US, Japan and Europe.

from IndiaTV India: Google News Feed https://ift.tt/2FTj9m7
via